Pingkian, Ruro Alistair .

HRN: 22-57-91  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/06/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/06/2023
02/12/2023
IVT
550mg
Q6
Pcap D, Submandibular Mass
Waiting Final Action 
02/06/2023
OXACILLIN 500MG (VIAL)
02/06/2023
02/12/2023
IVT
170mg
Q6
Pcap D, Submandibular Mass
Waiting Final Action 
02/07/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/07/2023
02/14/2023
IV
70mg
Q8
DIC; PCAP D; Pleural Effusion, Left; Submandibular Abscess
Waiting Final Action 
02/11/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
02/11/2023
02/11/2023
IV
135mg
OD
Fungal Pneumonia
Waiting Final Action 
02/14/2023
OXACILLIN 500MG (VIAL)
02/14/2023
02/21/2023
IV
170
Q6hrs
Sepsis
Waiting Final Action 
02/21/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
02/21/2023
02/23/2023
IV
65 Mg
Q24
Empyema Thoracis, PCAP; Fungal Pneumonia
Waiting Final Action 
02/21/2023
CIPROFLOXACIN 500MG (TAB)
02/21/2023
02/28/2023
PO
90mg
Bid
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: